Search - tctmd.com

Displaying 1 - 20 of 367

Sort: Relevancy | Date

News Daily News

Telemedicine May Adversely Impact Care Quality for HF Patients

Caitlin E. Cox

January 26, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Daily News

ANOCA May Not Be as Risky as Feared: Danish Data

Caitlin E. Cox

December 15, 2025

News Daily News

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

Todd Neale

December 15, 2025

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Caitlin E. Cox

November 21, 2025

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Todd Neale

November 14, 2025

News Conference News AHA 2025

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Yael L. Maxwell

November 12, 2025

News Conference News TCT 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

Caitlin E. Cox

October 28, 2025

Presentation TCT 2025

TCT 801: Comparative Efficacy and Safety of Beta Blockers Versus SGLT2 Inhibitors in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)

Presenter: Mehmet Cilingiroglu

October 27, 2025

News Conference News EACTS 2025

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Yael L. Maxwell

October 13, 2025

News Conference News HFSA 2025

Too Few HF Patients on Guideline-Directed Medical Therapy in VA System

Yael L. Maxwell

October 06, 2025

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

Presentation ESC 2025

BETAMI-DANBLOCK: Randomized Discontinuation of Beta-blockers After Myocardial Infarction in Patients Without Heart Failure

Presenter: Eva Prescott, Dan Atar

August 30, 2025

Presentation ESC 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Presenter: Borja Ibanez

August 30, 2025

News Conference News ESC 2025

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

Caitlin E. Cox

August 30, 2025

News Conference News ESC 2025

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support

Todd Neale

August 30, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

Advertisement

Telemedicine May Adversely Impact Care Quality for HF Patients

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

FDA Approves Aficamten for Obstructive HCM

ANOCA May Not Be as Risky as Feared: Danish Data

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

TCT 801: Comparative Efficacy and Safety of Beta Blockers Versus SGLT2 Inhibitors in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Too Few HF Patients on Guideline-Directed Medical Therapy in VA System

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

BETAMI-DANBLOCK: Randomized Discontinuation of Beta-blockers After Myocardial Infarction in Patients Without Heart Failure

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content